Hannah is an Associate in the IP Disputes team at Osborne Clarke and has a particular interest in biotech, healthcare and technology. Hannah advises clients on IP strategy, licensing and disputes, focusing on patent disputes in tech and life sciences. Hannah also assists clients with trade mark management and copyright advice.
Hannah holds a degree in natural sciences and has experience working in industry and as part of university research teams. Before studying law, Hannah worked as a strategy and contracts manager at Imperial College London; working with research groups, commercial industry partners and university spin-outs.
During a six-month secondment to BioNTech, Hannah worked as part of the in-house legal team to negotiate research collaboration agreements, IP licences and framework agreements for clinical trials.
Hannah has a Postgraduate Diploma in IP Law from the University of Oxford.
Helping you succeed in tomorrow's world
Hannah is passionate about enabling access education and social mobility. Hannah has worked as a mentor at OC and supported a number of events as part of the OC REACH network (Race, Ethnicity and Cultural Heritage).
Amgen
Acted for Amgen in UK High Court proceedings (patent revocation and infringement) regarding two patents relating to aflibercept formulations.
Amgen
Advising on biosimilar litigation in the UK and a preliminary injunction in the UPC, relating to the launch of Amgen's product BEKEMV® (eculizumab).
Software client
Advised an international software and technology company on it's IP rights to protect proprietary software and licence negotiations.
ITC Limited
Advised ITC Limited on its trade mark and brand strategy in regard to parallel imports of consumer products.
